These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 22986243

  • 1. Quantification by energy dispersive x-ray spectroscopy of alendronate in the diseased jaw bone of patients with bisphosphonate-related jaw osteonecrosis.
    Schaudinn C, Gorur A, Webster P, Jones AC, Neely M, Jelliffe RW, Le AD, Sedghizadeh PP.
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Oct; 114(4):480-6. PubMed ID: 22986243
    [Abstract] [Full Text] [Related]

  • 2. Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates.
    Lazarovici TS, Mesilaty-Gross S, Vered I, Pariente C, Kanety H, Givol N, Yahalom R, Taicher S, Yarom N.
    J Oral Maxillofac Surg; 2010 Sep; 68(9):2241-7. PubMed ID: 20728033
    [Abstract] [Full Text] [Related]

  • 3. [Vitamin D and bisphosphonate-related osteonecrosis of the jaw (BRONJ) ].
    Hokugo A.
    Clin Calcium; 2012 Jan; 22(1):83-90. PubMed ID: 22201103
    [Abstract] [Full Text] [Related]

  • 4. Osteonecrosis of the jaw in Sweden associated with the oral use of bisphosphonate.
    Ulmner M, Jarnbring F, Törring O.
    J Oral Maxillofac Surg; 2014 Jan; 72(1):76-82. PubMed ID: 23992777
    [Abstract] [Full Text] [Related]

  • 5. Osteonecrosis of the jaws in patients assuming oral bisphosphonates for osteoporosis: a retrospective multi-hospital-based study of 87 Italian cases.
    Di Fede O, Fusco V, Matranga D, Solazzo L, Gabriele M, Gaeta GM, Favia G, Sprini D, Peluso F, Colella G, Vescovi P, Campisi G.
    Eur J Intern Med; 2013 Dec; 24(8):784-90. PubMed ID: 23768563
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the prognosis of bisphosphonate-related osteonecrosis of the jaw caused by oral and intravenous bisphosphonates.
    Shintani T, Hayashido Y, Mukasa H, Akagi E, Hoshino M, Ishida Y, Hamana T, Okamoto K, Kanda T, Koizumi K, Yoshioka Y, Tani R, Toratani S, Okamoto T.
    Int J Oral Maxillofac Surg; 2015 Jul; 44(7):840-4. PubMed ID: 25861974
    [Abstract] [Full Text] [Related]

  • 7. A Strategy against the Osteonecrosis of the Jaw Associated with Nitrogen-Containing Bisphosphonates (N-BPs): Attempts to Replace N-BPs with the Non-N-BP Etidronate.
    Oizumi T, Yamaguchi K, Sato K, Takahashi M, Yoshimura G, Otsuru H, Tsuchiya M, Hagiwara Y, Itoi E, Sugawara S, Takahashi T, Endo Y.
    Biol Pharm Bull; 2016 Jul; 39(9):1549-54. PubMed ID: 27582334
    [Abstract] [Full Text] [Related]

  • 8. Resolution of oral bisphosphonate and steroid-related osteonecrosis of the jaw--a serial case analysis.
    Chiu CT, Chiang WF, Chuang CY, Chang SW.
    J Oral Maxillofac Surg; 2010 May; 68(5):1055-63. PubMed ID: 20403529
    [Abstract] [Full Text] [Related]

  • 9. Outcome of surgical management of bisphosphonate-related osteonecrosis of the jaws: review of 33 surgical cases.
    Stanton DC, Balasanian E.
    J Oral Maxillofac Surg; 2009 May; 67(5):943-50. PubMed ID: 19375001
    [Abstract] [Full Text] [Related]

  • 10. Molecular interaction between bisphosphonates and human bone: a preliminary study on osteonecrosis sequesters of the jaw.
    Olejnik C, Falgayrac G, Vieillard MH, Maes JM, Penel G.
    Bull Group Int Rech Sci Stomatol Odontol; 2011 Sep 23; 50(1):52-3. PubMed ID: 22750602
    [No Abstract] [Full Text] [Related]

  • 11. Osteonecrosis of the jaw and nonmalignant disease: is there an association with rheumatoid arthritis?
    Lescaille G, Coudert AE, Baaroun V, Javelot MJ, Cohen-Solal M, Berdal A, Goudot P, Azérad J, Ruhin B, Descroix V.
    J Rheumatol; 2013 Jun 23; 40(6):781-6. PubMed ID: 23504384
    [Abstract] [Full Text] [Related]

  • 12. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
    Carlson ER, Basile JD.
    J Oral Maxillofac Surg; 2009 May 23; 67(5 Suppl):85-95. PubMed ID: 19371819
    [Abstract] [Full Text] [Related]

  • 13. [Basic Studies on the Mechanism, Prevention, and Treatment of Osteonecrosis of the Jaw Induced by Bisphosphonates].
    Endo Y, Funayama H, Yamaguchi K, Monma Y, Yu Z, Deng X, Oizumi T, Shikama Y, Tanaka Y, Okada S, Kim S, Kiyama T, Bando K, Shima K, Suzuki H, Takahashi T.
    Yakugaku Zasshi; 2020 May 23; 140(1):63-79. PubMed ID: 31902887
    [Abstract] [Full Text] [Related]

  • 14. Oral bisphosphonate-associated osteonecrosis of the jaw after implant surgery: a case report and literature review.
    Bedogni A, Bettini G, Totola A, Saia G, Nocini PF.
    J Oral Maxillofac Surg; 2010 Jul 23; 68(7):1662-6. PubMed ID: 20561470
    [Abstract] [Full Text] [Related]

  • 15. The role of bisphosphonates in medical oncology and their association with jaw bone necrosis.
    Eid A, Atlas J.
    Oral Maxillofac Surg Clin North Am; 2014 May 23; 26(2):231-7. PubMed ID: 24794267
    [Abstract] [Full Text] [Related]

  • 16. The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data.
    Allen MR, Burr DB.
    J Oral Maxillofac Surg; 2009 May 23; 67(5 Suppl):61-70. PubMed ID: 19371816
    [Abstract] [Full Text] [Related]

  • 17. Nationwide survey for bisphosphonate-related osteonecrosis of the jaws in Japan.
    Urade M, Tanaka N, Furusawa K, Shimada J, Shibata T, Kirita T, Yamamoto T, Ikebe T, Kitagawa Y, Fukuta J.
    J Oral Maxillofac Surg; 2011 Nov 23; 69(11):e364-71. PubMed ID: 21782307
    [Abstract] [Full Text] [Related]

  • 18. Risk of atypical femoral fractures and osteonecrosis of the jaw associated with alendronate use compared with other oral bisphosphonates.
    Kharazmi M, Hallberg P, Warfvinge G, Michaëlsson K.
    Rheumatology (Oxford); 2014 Oct 23; 53(10):1911-3. PubMed ID: 25099769
    [No Abstract] [Full Text] [Related]

  • 19. Association of laser phototherapy with PRP improves healing of bisphosphonate-related osteonecrosis of the jaws in cancer patients: a preliminary study.
    Martins MA, Martins MD, Lascala CA, Curi MM, Migliorati CA, Tenis CA, Marques MM.
    Oral Oncol; 2012 Jan 23; 48(1):79-84. PubMed ID: 21940198
    [Abstract] [Full Text] [Related]

  • 20. Teriparatide therapy for bisphosphonate-related osteonecrosis of the jaw: a case report and narrative review.
    Thumbigere-Math V, Gopalakrishnan R, Michalowicz BS.
    Northwest Dent; 2013 Jan 23; 92(1):12-8. PubMed ID: 23516715
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.